Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,648 | 800 | 73.7% |
| Debt forgiveness | $4,733 | 1 | 25.5% |
| Education | $145.92 | 12 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GE HealthCare | $4,733 | 1 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,632 | 87 | $0 (2024) |
| Novo Nordisk Inc | $1,148 | 77 | $0 (2024) |
| ABBVIE INC. | $1,114 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $939.61 | 75 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $818.39 | 43 | $0 (2024) |
| PFIZER INC. | $768.79 | 54 | $0 (2024) |
| Amgen Inc. | $698.46 | 35 | $0 (2024) |
| Lilly USA, LLC | $674.90 | 42 | $0 (2024) |
| Astellas Pharma US Inc | $523.68 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,798 | 80 | Novo Nordisk Inc ($220.41) |
| 2023 | $1,565 | 82 | ABBVIE INC. ($229.46) |
| 2022 | $6,689 | 102 | GE HealthCare ($4,733) |
| 2021 | $1,924 | 110 | AbbVie Inc. ($349.51) |
| 2020 | $1,550 | 87 | AstraZeneca Pharmaceuticals LP ($285.27) |
| 2019 | $1,566 | 94 | Janssen Pharmaceuticals, Inc ($213.02) |
| 2018 | $1,722 | 127 | AstraZeneca Pharmaceuticals LP ($226.24) |
| 2017 | $1,713 | 131 | AstraZeneca Pharmaceuticals LP ($212.33) |
All Payment Transactions
813 individual payment records from CMS Open Payments — Page 1 of 33
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $5.66 | General |
| Category: Oncology | ||||||
| 10/31/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $25.27 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: VACCINES | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.01 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: DIABETES | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Inflammation | ||||||
| 10/07/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: Bone Health | ||||||
| 10/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: RESPIRATORY | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Oncology | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $2.95 | General |
| Category: Oncology | ||||||
| 09/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: Diabetes | ||||||
| 09/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Obesity | ||||||
| 09/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: Biological | ||||||
| 09/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: Diabetes Care | ||||||
| 08/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Obesity | ||||||
| 08/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 628 | 940 | $189,964 | $89,723 |
| 2022 | 6 | 775 | 1,136 | $151,810 | $94,135 |
| 2021 | 8 | 859 | 1,181 | $154,770 | $104,046 |
| 2020 | 7 | 825 | 1,151 | $150,770 | $79,413 |
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 448 | $89,550 | $43,206 | 48.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 98 | 98 | $41,160 | $18,073 | 43.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 136 | 234 | $35,100 | $16,719 | 47.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 56 | 56 | $16,800 | $8,109 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 14 | $3,850 | $2,075 | 53.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 54 | 54 | $2,064 | $1,107 | 53.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 36 | $1,440 | $434.28 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 493 | $76,415 | $47,290 | 61.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 150 | 150 | $29,250 | $22,505 | 76.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 154 | 265 | $34,450 | $17,894 | 51.9% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 156 | 156 | $5,460 | $3,317 | 60.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 17 | $3,485 | $2,554 | 73.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 53 | 55 | $2,750 | $574.60 | 20.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 273 | 530 | $82,150 | $55,329 | 67.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 175 | 175 | $34,125 | $26,819 | 78.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 110 | 166 | $21,580 | $12,538 | 58.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 182 | 182 | $6,370 | $4,023 | 63.2% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 22 | 23 | $4,715 | $3,772 | 80.0% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 68 | 74 | $3,700 | $882.63 | 23.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 11 | 12 | $1,750 | $615.72 | 35.2% |
| 81002 | Urinalysis, manual test | Office | 2021 | 18 | 19 | $380.00 | $66.12 | 17.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 260 | 497 | $77,035 | $39,308 | 51.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 168 | 168 | $32,760 | $22,365 | 68.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 142 | 228 | $29,640 | $11,990 | 40.5% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 184 | 184 | $6,440 | $3,843 | 59.7% |
About Dr. Zaid Khalil, M.D
Dr. Zaid Khalil, M.D is a Family Medicine healthcare provider based in Vienna, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629001797.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Zaid Khalil, M.D has received a total of $18,527 in payments from pharmaceutical and medical device companies, with $1,798 received in 2024. These payments were reported across 813 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($13,648).
As a Medicare-enrolled provider, Khalil has provided services to 3,087 Medicare beneficiaries, totaling 4,408 services with total Medicare billing of $367,317. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Vienna, VA
- Active Since 07/09/2006
- Last Updated 04/22/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1629001797
Products in Payments
- FARXIGA (Drug) $1,122
- UBRELVY (Drug) $531.76
- TRELEGY ELLIPTA (Drug) $493.45
- Ozempic (Drug) $456.59
- JARDIANCE (Drug) $454.23
- QULIPTA (Drug) $383.16
- XARELTO (Drug) $364.85
- ELIQUIS (Drug) $356.40
- Vascepa (Drug) $310.32
- Cologuard Collection Kit (Device) $275.89
- INJECTAFER (Drug) $265.04
- Wegovy (Drug) $258.77
- EVENITY (Biological) $238.60
- Kerendia (Drug) $232.52
- MOUNJARO (Drug) $226.21
- Otezla (Drug) $225.24
- TRULICITY (Drug) $211.29
- TRADJENTA (Drug) $209.22
- NEXLETOL (Drug) $207.02
- VRAYLAR (Drug) $193.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Vienna
Dr. Barbara Mackie, Md, MD
Family Medicine — Payments: $10,097
Dr. Daniel Fitzpatrick, D.o, D.O
Family Medicine — Payments: $8,014
Dr. Barnett Mennen, M.d, M.D
Family Medicine — Payments: $4,521
Ernest Miller, Do, DO
Family Medicine — Payments: $4,057
Dr. Daniel Merenstein, Md, MD
Family Medicine — Payments: $3,041
Dennis Newland, Md, MD
Family Medicine — Payments: $2,955